Figures
Abstract
The extensive health benefits of smoking cessation are undeniable; however, for many patients the concept of quitting can be daunting and difficult. An individualised combination of behavioural support and pharmacological interventions can help support patients to quit smoking.
Key Points
- Smoking continues to be prevalent in our society and the use of e-cigarettes is increasing.
- Smoking is associated with detrimental health effects, including a higher risk of hospitalisation and death with COVID-19.
- Behavioural support along with treatment of nicotine dependence is the most effective approach to supporting smoking cessation.
- First-line pharmacotherapy options are nicotine replacement therapy, varenicline and bupropion.
- Nicotine e-cigarettes may assist some smokers to quit but there is a lack of evidence regarding efficacy and safety.
